Clinical Trials Sponsored by Feeding America

Total 4745 results

Sumitomo Pharma America, Inc.

Completed

A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma

Glioblastoma

United States, Canada
Sumitomo Pharma America, Inc.

Completed

A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers

Cancer

United States
Sumitomo Pharma America, Inc.

Completed

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

Cancer

Canada, United States
Sumitomo Pharma America, Inc.

Terminated

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLL

United States
Sumitomo Pharma America, Inc.

Terminated

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Myelodysplastic Syndromes (MDS)

United States
Sumitomo Pharma America, Inc.

Terminated

Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

Acute Myeloid Leukemia (AML)

United States
Sumitomo Pharma America, Inc.

Completed

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Oncology

United States, Taiwan, Japan, France
Merz North America, Inc.

Terminated

Longitudinal Evaluation and Real-world Evidence of NT201

Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

United States
Merz North America, Inc.

Completed

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds

Correction of Moderate to Severe Nasolabial Folds (NLFs)

China
Merz North America, Inc.

Completed

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China

Correction of the Moderate to Severe Nasolabial Folds

China
Merz North America, Inc.

Completed

Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds

Correction of Moderate to Severe Nasolabial Folds

United States
Merz North America, Inc.

Completed

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

Tinea Corporis

United States, Dominican Republic, Honduras
Merz North America, Inc.

Withdrawn

Safety and Efficacy of NAFT900 in Children With Tinea Capitis

Tinea Capitis
Merz North America, Inc.

Withdrawn

Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older (MSRD-100)

Atopic Dermatitis
Maruho North America Inc.

Completed

Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Maruho North America Inc.

Completed

Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers

Healthy Volunteers

United States
Merz North America, Inc.

Completed

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

Tinea Cruris | Jock Itch

Belize, Dominican Republic, Honduras
Merz North America, Inc.

Completed

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (NAFT-600)

Tinea Pedis

United States, Puerto Rico
Merz North America, Inc.

Completed

Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler

Nasolabial Folds

United States
Merz North America, Inc.

Completed

Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI

Facial Wrinkles

United States
Merz North America, Inc.

Completed

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

Tinea Cruris | Jock Itch

United States, Puerto Rico
Clinique Ovo
Ferring Pharmaceuticals

Completed

Personalizing Window of Implantation During Frozen Embryo Transfer (AdhesioRT)

Fertility

Canada
University of Reading
Naturex

Completed

Enhancement of Sleep Quality and Mood Following Supplementation With Lemon Balm in an Adult Population (Lemslp)

Sleep Disturbance | Mood Disturbance

United Kingdom
Yale University
NIH (pending)

Withdrawn

New Model of Stroke Education

Stroke

United States
Lund University
Ferring Pharmaceuticals

Completed

Hormone Evaluation in Artificial Reproductive Technology (HEART)

Female Infertility

Poland, Sweden
Boston Image Reading Center

Active, not recruiting

Non Exudative AMD Imaged With SS-OCT (BIRC-01)

Dry Macular Degeneration

United States, Australia
Nordsjaellands Hospital
Ferring Pharmaceuticals

Terminated

Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis

Inflammatory Bowel Diseases | Ulcerative Colitis

Denmark
University of Reading
Naturex

Completed

Investigating the Acute and Chronic Effects of an American Ginseng Root Extract on Cognition and Mood

Cognitive Change | Effects of Ginseng on Cognitive Function

United Kingdom
Lady Reading Hospital, Pakistan

Completed

Half-thickness Tragal Cartilage Graft vs Temporalis Fascia Graft Tympanoplasty Type I (PTA)

Hearing Loss,Conductive

Pakistan
CMX Research
Ferring Pharmaceuticals

Completed

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (DELAY)

Prostate Cancer

Canada
Clasado
University of Reading

Completed

Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults

Metabolic Syndrome X

United Kingdom
University of Reading
GlaxoSmithKline

Completed

Anthocyanin-rich Blackcurrant and Vascular Function

Inflammation | Vascular Stiffness

United Kingdom
American Dental Association
American Dental Hygienists Association

Completed

COVID-19-Related Health and Practices Among Dental Hygienists

Depression | Severe Acute Respiratory Syndrome | Coronavirus Infection | Anxiety | SARS-CoV Infection | Occupational Problems

United States
University of Reading
INNOPURE

Not yet recruiting

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Autism

United Kingdom
Clinique Ovo
Ferring Pharmaceuticals

Recruiting

Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation (Ooxyd)

Fertility Preservation

Canada
Clinique Ovo
Ferring Pharmaceuticals

Active, not recruiting

Rescue Progesterone Supplementation During Frozen Embryo Transfer (P4R)

Fertility Issues | Frozen Embryo Transfer | Embryo Implantation

Canada
Doheny Image Reading Center

Withdrawn

Image Biomarkers for Progression of AMD (IBPAMD)

AMD
Natera, Inc.
Ferring Pharmaceuticals

Terminated

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer (IPSO)

In Vitro Fertilization (IVF) | Preimplantation Genetic Diagnosis (PGD) | Preimplantation Gentic Screening (PGS)

United States
University of Reading
Danisco

Completed

A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers (XOS)

Gut Microbiota | Immune Function | Bowel Function | Plasma Lipids

United Kingdom
University Hospital, Basel, Switzerland
Leading House for the Latin American Region (Seed Money Grant SMG 1730)

Withdrawn

Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology

Borderline Personality Disorder (BPD)
Mitsubishi Tanabe Pharma America Inc.

Recruiting

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP (INSPIRE)

Erythropoietic Protoporphyria (EPP) | X-Linked Protoporphyria (XLP)

Spain, United States, France, Japan, United Kingdom, Italy, Australia, Poland, Bulgaria, Czechia, Netherlands
Fresenius Medical Care North America

Recruiting

SAfety of Regional Citrate Anticoagulation (SARCA Study) (SARCA)

Acute Kidney Injury | ESRD

United States
Mitsubishi Tanabe Pharma America Inc.

Recruiting

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Spinal Cord Injury

United States, Canada, Japan
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Erythropoietic Protoporphyria (EPP)

United States
Mitsubishi Tanabe Pharma America Inc.

Terminated

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Korea, Republic of, Canada, Germany, Japan, Italy, Switzerland
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Endometrial Related Pain

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

Healthy Subjects

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS

United States, Canada, Japan, France, Germany, Italy
Mitsubishi Tanabe Pharma America Inc.

Completed

Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor (MT-7117 BA DDI)

Healthy Volunteer

Germany
Mitsubishi Tanabe Pharma America Inc.

Completed

Definitive QT Study With MT-8554 (MT-8554 DQT)

Healthy Volunteer

United Kingdom

Clinical Trials Sponsored by Feeding America

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations